Sidley, partnering with Morgan, Lewis & Bockius, Cosmich, Simmons & Brown, and Foley Mansfield, has represented Merck & Co. Merck & Co. achieved a significant victory...
Merck & Co. Prevails in Illinois Product Liability Trial Over Talcum Powder
Merck to Acquire Terns Pharmaceuticals for $6.7 Billion
Covington & Burling LLP and Gibson Dunn & Crutcher LLP have advised Merck & Co., Inc. Freshfields has advised Terns Pharmaceuticals, Inc. Merck & Co., Inc.,...
Merck’s $3.9 Billion Acquisition of SpringWorks Therapeutics
Sullivan & Cromwell advised Merck KGaA, Darmstadt, Germany, while Goodwin Procter advised SpringWorks Therapeutics on the transaction. Skadden advised Centerview Partners and Goldman Sachs & Co....
Merck’s License Agreement with LaNova
Gibson Dunn & Crutcher advised Merck on the transaction and Wilson Sonsini Goodrich & Rosati advised LaNova Medicines. Merck (NYSE: MRK), known as MSD outside of...
Bueno v. Merck & Co.
King & Spalding secured final summary judgments for Merck and Organon in the first two cases to be prepared for trial in a major nationwide pharmaceutical...
Merck’s Acquisition Of Investigational B-Cell Depletion Therapy (CN201) From Curon Biopharmaceutical
Hogan Lovells acted as Merck’s legal advisor in this transaction. Centerview Partners LLC acted as financial advisor to Curon and Goodwin Procter LLP as the company’s...
Merck’s Acquisition of Prometheus Biosciences
Paul, Weiss, Rifkind, Wharton & Garrison represented Merck, Latham & Watkins represented Prometheus, Skadden represented the financial advisors on the deal. Prometheus Biosciences, Inc. have entered...
Merck’s License and Collaboration Agreement with Kelun-Biotech
Morgan Lewis represented Merck in the transaction. Merck closed its exclusive license and collaboration agreement with Kelun-Biotech, a holding subsidiary of Sichuan Kelun Pharmaceutical Co. Ltd., to...
Merck’s $8 Billion Notes Offering
Fried Frank acted as counsel to Merck & Co., while Davis Polk advised the representatives of the underwriters on the offering. Merck & Co., Inc. issued...